PRM58 - IMPACT OF FUTURE COSTS IN COST-EFFECTIVENESS ANALYSES AND A COMPARISON OF DIRECT AND INDIRECT METHODS USING MODELS OF CABAZITAXEL IN PROSTATE CANCER AND CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2180
https://www.valueinhealthjournal.com/article/S1098-3015(18)35482-2/fulltext
Title :
PRM58 - IMPACT OF FUTURE COSTS IN COST-EFFECTIVENESS ANALYSES AND A COMPARISON OF DIRECT AND INDIRECT METHODS USING MODELS OF CABAZITAXEL IN PROSTATE CANCER AND CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35482-2&doi=10.1016/j.jval.2018.09.2180
First page :
Section Title :
Open access? :
No
Section Order :
1527